Cargando…

Distant Nodes Seen on PSMA PET-CT Staging Predicts Post-Treatment Progression in Men with Newly Diagnosed Prostate Cancer—A Prospective Cohort Study

SIMPLE SUMMARY: PSMA PET-CT is a new scan which has now been proven to be the most accurate in detecting prostate cancer outside the prostate gland. It is now recommended by international guidelines to be used before treatment is commenced for prostate cancer. However, we still do not know the true...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ong, Sean, Pascoe, Claire, Kelly, Brian D., Ballok, Zita, Webb, David, Bolton, Damien, Murphy, Declan, Sengupta, Shomik, Bowden, Patrick, Lawrentschuk, Nathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777123/ https://www.ncbi.nlm.nih.gov/pubmed/36551620 http://dx.doi.org/10.3390/cancers14246134

Ejemplares similares

PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer—A Prospective Study of Men with 3 Year Follow Up
por: Ong, Sean, et al.
Publicado: (2022)

Cribriform pattern disease over‐represented in pelvic lymph node metastases identified on (68)GA PSMA‐PET/CT
por: Bolton, Damien, et al.
Publicado: (2022)

Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma
por: Crozier, Jack, et al.
Publicado: (2017)

PSMA-PET for Lymph Node Detection in Recurrent Prostate Cancer: How do we use the Magic Bullet?
por: Maurer, Tobias, et al.
Publicado: (2017)

Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy
por: Tan, Lynn, et al.
Publicado: (2018)

(18)F-PSMA-1007 PET/CT Performance on Risk Stratification Discrimination and Distant Metastases Prediction in Newly Diagnosed Prostate Cancer
por: Wang, Zhuonan, et al.
Publicado: (2021)

The Role of Lymph Node Fine-Needle Aspiration in Penile Cancer in the Sentinel Node Era
por: Mir, Maria Carmen, et al.
Publicado: (2011)

Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer—a narrative review
por: Ong, Sean, et al.
Publicado: (2021)

Australian patterns of prostate cancer care: Are they evolving?
por: Lo, Jonathon, et al.
Publicado: (2016)

Role of pelvic lymph node dissection in bladder cancer: is it better to do more?
por: Dat, Anthony, et al.
Publicado: (2019)

Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer
por: Alberto, Matthew, et al.
Publicado: (2022)

Retroperitoneal lymph node dissection for germ cell tumour
por: Tran, Vy, et al.
Publicado: (2020)

(68)Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial
por: Bowden, Patrick, et al.
Publicado: (2021)

Accuracy of (68)Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer
por: Barbosa, Álan Roger Gomes, et al.
Publicado: (2022)

PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer
por: Tran, Vy, et al.
Publicado: (2022)

Subinguinal orchiectomy—A minimally invasive approach to open surgery
por: Anderson, Elliot, et al.
Publicado: (2020)

Review of the use of prophylactic drain tubes post‐robotic radical prostatectomy: Dogma or decent practice?
por: Nzenza, Tatenda C., et al.
Publicado: (2020)

Prostate cancer screening in Primary Health Care: the current state of affairs
por: Ranasinghe, Weranja KB, et al.
Publicado: (2015)

Prostate cancer nodal oligometastasis accurately assessed using prostate-specific membrane antigen positron emission tomography-computed tomography and confirmed histologically following robotic-assisted lymph node dissection
por: O’Kane, Dermot B., et al.
Publicado: (2016)

(68)Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer
por: Iravani, Amir, et al.
Publicado: (2017)

A narrative review of pelvic lymph node dissection in prostate cancer
por: Cheung, Douglas C., et al.
Publicado: (2020)

PSMA PET in Imaging Prostate Cancer
por: Tsechelidis, Ioannis, et al.
Publicado: (2022)

All that Glitters on PSMA is Not a Lesion: An Unusual Artifact on PSMA PET/CT
por: Dev, Indraja D., et al.
Publicado: (2021)

Advanced PSMA-PET/CT Imaging Parameters in Newly Diagnosed Prostate Cancer Patients for Predicting Metastatic Disease
por: Yechiel, Yaniv, et al.
Publicado: (2023)

Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study
por: Donswijk, Maarten L., et al.
Publicado: (2020)

Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer
por: Guo, Kaibo, et al.
Publicado: (2020)

PSMA Expression in Multinodular Thyroid Neoplasm on Simultaneous Ga-68-PSMA PET/MRI
por: Jena, Amarnath, et al.
Publicado: (2017)

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
por: Ceci, Francesco, et al.
Publicado: (2021)

Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET
por: Leung, Kevin H., et al.
Publicado: (2022)

Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023)

Expanding the role of PSMA PET in active surveillance
por: Jain, Anika, et al.
Publicado: (2023)

PSMA-PET in the early stages of prostate cancer
por: Barbosa, Felipe de Galiza
Publicado: (2023)

PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review
por: Petersen, Lars J., et al.
Publicado: (2020)

The role of (18)F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!
por: Hung, Te-Jui, et al.
Publicado: (2019)

On the matching of seen and felt shape by newly sighted subjects
por: Schwenkler, John
Publicado: (2012)

Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy
por: Chan, Tsz Him, et al.
Publicado: (2023)

FDG-PET Versus PSMA-PET: A Patient With Prostate Cancer
por: Kichloo, Asim, et al.
Publicado: (2020)

Multiparametric dynamic whole-body PSMA PET/CT using [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007
por: Dias, André H., et al.
Publicado: (2023)

PSMA-PET/CT-Positive Paget Disease in a Patient with Newly Diagnosed Prostate Cancer: Imaging and Bone Biopsy Findings
por: Froehner, Michael, et al.
Publicado: (2017)

Interobserver agreement of [(68)Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer
por: Derwael, Céline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b0b4bufjpg0evogar3vogllvu5